In the specialized field of molecular biology and protein biochemistry, the 3xha peptide has become an indispensable tool for researchers. As someone deeply involved in laboratory-based protein analysis, I have found that understanding the nuances of these synthetic constructs is essential for achieving high-fidelity results.
Understanding the 3xha Peptide Structure
The 3xha peptide is a bioactive peptide consisting of three repetitive HA tags, specifically the nine-amino-acid sequence (YPYDVPDYA). This sequence is derived from the human influenza hemagglutinin (HA) protein, which is naturally responsible for attaching the virus to cell receptors and initiating infection. By concatenating this epitope three times, the resulting 3xHA construct provides a significantly higher binding affinity for anti-HA antibodies compared to a single tag.
Technically, the 3xha peptide is a biological active peptide that serves as a robust platform for protein tagging. Because it is a peptide tag composed of three repeated hemagglutinin epitopes, it i 3X HA Tag - Bioactive peptide s commonly used to detect proteins and peptides with high specificity. Whether you are using a pCMV6-AC-3HA vector or working with a pCDNA-3xHA-hTERT plasmid, the integration of this tag is a standard procedure for facilitating functional analysis of proteins of interest Use HA synthetic peptide to elute 3x HA-tagged proteins off .
Practical Applications and Technical Considerations
In my experience, the primary utility of this construct lies in its versatility. It is a commonly used epitope or peptide tag that allows for the purification and identification of fusion proteins. For instance, HA peptide can be used to competitively elute HA-tagged fusion proteins from immobilized anti-HA magnetic beads. This is a critical step in native isolation protocols where maintaining the structural integrity of the protein complex is paramount.
However, researchers should be aware of potential limitations. As noted in various scientific repositories, chimeric proteins tagged with specific 3xHA cassettes may present instability and functional problems. When designing your experiments, it is vital to account for these potential conformatio pCMV6-AC-3HA Sequence and Map nal changes. Unlike the 3X FLAG peptide—which is an entirely synthetic polypeptide containing three repeated DYKXXD sequences—the HA system relies on its viral origin, which can sometimes influence the localization or stability of the target protein.
Best Practices for Detection and Elution
When performing Western blots or immunoprecipitation assays, the HA tag peptide (such as ab13835) acts as an excellent positive control or blocking agent. Many colleagues often ask if a synthetic 1x HA peptide can efficiently elute 3X HA-tagged proteins off from anti-HA resin. While it is possible, the use of the full 3xHA sequence often yields superior competitive elution efficiency due to the increased binding energy.
For those setting up a new expression system, utilizing a pMVP L5-L4 entry plasmid HA-tag - an overview containing the 3xHA epitope tag is a streamlined approach for 4-component MultiSite Gateway Pro assembly. This allows for N-terminal epitope tag fusion, which is often preferred when the C-terminus of the protein is required for biological activity. HA tag peptide (ab13835)
Conclusion
The 3xha peptide is a bioactive peptide that remains a cornerstone of modern biochemical analysis. Whether you are conducting a routine Western blo Chimeric proteins tagged with specific 3xHA cassettes may t or A comprehensive review on and purchase guide for HA tag antibodies, and a discussion of frequently asked questions about HA tag antibodies.Read more a complex native protein purification, the reliability of the 3xHA sequence is well-documented. By carefully selecting your expression vector—such as the pCMV6-AC-3HA—and understanding the elution dynamics of the HA peptide, you can significantly enhance the reproducibility of your research.
*Note: These products are for research use only and are not intended for human use or clinical diagnostics.*